Recombinant multi-species ITLN1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ITLN1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Enables calcium ion binding activity; identical protein binding activity; and oligosaccharide binding activity. Involved in positive regulation of glucose import; positive regulation of protein phosphorylation; and protein homotrimerization. Located in extracellular exosome. Part of receptor complex. [provided by Alliance of Genome Resources, Apr 2022]
The Alternative Names of target: Endothelial lectin HL-1,Galactofuranose-binding lectin,HL-1,HL1,INTL,ITLN,ITLN-1,ITLN1,IntL,Intelectin-1,Intestinal lactoferrin receptor,Itln,Itln1,Itln2,Itln3,Itln5,Itlna,LFR,Lfr,Omentin,hIntL,omentin

Target products collectionGo to ITLN1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0290-Ag-1/ GM-Tg-hg-SE0290-Ag-2 Human ITLN1 protein Human
GM-Tg-rg-SE0290-Ag-1/ GM-Tg-rg-SE0290-Ag-2 Rat ITLN1 protein Rat
GM-Tg-mg-SE0290-Ag-1/ GM-Tg-mg-SE0290-Ag-2 Mouse ITLN1 protein Mouse
GM-Tg-cynog-SE0290-Ag-1/ GM-Tg-cynog-SE0290-Ag-2 Cynomolgus/Rhesus macaque ITLN1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0290-Ag-1/ GM-Tg-felg-SE0290-Ag-2 Feline ITLN1 protein Feline
GM-Tg-cang-SE0290-Ag-1/ GM-Tg-cang-SE0290-Ag-2 Canine ITLN1 protein Canine
GM-Tg-bovg-SE0290-Ag-1/ GM-Tg-bovg-SE0290-Ag-2 Bovine ITLN1 protein Bovine
GM-Tg-equg-SE0290-Ag-1/ GM-Tg-equg-SE0290-Ag-2 Equine ITLN1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0290-Ag-1/ GM-Tg-hg-SE0290-Ag-2; GM-Tg-rg-SE0290-Ag-1/ GM-Tg-rg-SE0290-Ag-2;
GM-Tg-mg-SE0290-Ag-1/ GM-Tg-mg-SE0290-Ag-2; GM-Tg-cynog-SE0290-Ag-1/ GM-Tg-cynog-SE0290-Ag-2;
GM-Tg-felg-SE0290-Ag-1/ GM-Tg-felg-SE0290-Ag-2; GM-Tg-cang-SE0290-Ag-1/ GM-Tg-cang-SE0290-Ag-2;
GM-Tg-bovg-SE0290-Ag-1/ GM-Tg-bovg-SE0290-Ag-2; GM-Tg-equg-SE0290-Ag-1/ GM-Tg-equg-SE0290-Ag-2
Products Name ITLN1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ITLN1
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ITLN1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.